Last updated: 3 months ago
Anebulo Pharmaceuticals Financial Report: Losses, Risks & Stock Outlook
Explore Anebulo Pharmaceuticals' latest financial report detailing a $4.7M net loss, funding updates, and investment recommendations amidst regulatory challenges.